Pharmacogenetics of smoking: how far to the clinic?-Reference-Cited by-同舟云学术

Pharmacogenetics of smoking: how far to the clinic?

Published:2014-04 Issue:6 Volume:15 Page:723-726
ISSN:1462-2416
Container-title:Pharmacogenomics
language:en
Short-container-title:Pharmacogenomics

Author:

Quaak Marieke¹,van Schooten Frederik J²,van Schayck Constant P³

Affiliation:

1. Maastricht University, School for Public Health & Primary Care (CAPHRI), Department of General Practice, Maastricht, The Netherlands and Maastricht University, School for Nutrition, Toxicology & Metabolism (NUTRIM), Department of Toxicology, PO Box 616, 6200 MD, Maastricht, The Netherlands

2. Maastricht University, School for Nutrition, Toxicology & Metabolism (NUTRIM), Department of Toxicology, Maastricht, The Netherlands

3. Maastricht University, School for Public Health & Primary Care (CAPHRI), Department of General Practice, Maastricht, The Netherlands

Publisher

Future Medicine Ltd

Subject

Pharmacology,Genetics,Molecular Medicine

Link

https://www.futuremedicine.com/doi/pdf/10.2217/pgs.14.34

Reference18 articles.

1. GuindonGE, Boisclair D. Past, current and future trends in tobacco use. HNP discussion paper no. 6. Econcomics of tobacco control paper no. 6 (2003).http://hdl.handle.net/10986/13726

2. Benefits of Smoking Cessation for Longevity

3. Genetic variation as a predictor of smoking cessation success. A promising preventive and intervention tool for chronic respiratory diseases?

4. Individualizing Nicotine Replacement Therapy for the Treatment of Tobacco Dependence

5. Predictors of 12-Month Outcome in??Smokers Who Received Bupropion??Sustained-Release for??Smoking Cessation

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacogenetics factors influencing smoking cessation success; the importance of nicotine metabolism;Expert Opinion on Drug Metabolism & Toxicology;2020-12-29

2. CHRNA4 rs1044396 is associated with smoking cessation in varenicline therapy;Frontiers in Genetics;2015-02-27